LifeVantage (NASDAQ:LFVN) Releases FY 2025 Earnings Guidance

LifeVantage (NASDAQ:LFVNGet Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.700-0.800 for the period, compared to the consensus EPS estimate of 0.720. The company issued revenue guidance of $200.0 million-$210.0 million, compared to the consensus revenue estimate of $204.8 million.

LifeVantage Trading Down 3.8 %

NASDAQ:LFVN traded down $0.51 on Tuesday, hitting $12.98. 172,827 shares of the company’s stock traded hands, compared to its average volume of 59,519. LifeVantage has a 1 year low of $4.20 and a 1 year high of $14.71. The company has a market cap of $164.86 million, a PE ratio of 46.36 and a beta of 0.84. The firm has a 50-day moving average price of $10.68 and a 200-day moving average price of $8.27.

LifeVantage (NASDAQ:LFVNGet Free Report) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.07). LifeVantage had a net margin of 1.47% and a return on equity of 27.85%. The business had revenue of $48.93 million during the quarter.

LifeVantage Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 17th. Investors of record on Monday, September 9th were paid a dividend of $0.04 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $0.16 annualized dividend and a yield of 1.23%. LifeVantage’s dividend payout ratio is 57.14%.

LifeVantage Company Profile

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Recommended Stories

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.